 |
Articles Area
Home Login / Register Browse Articles Search Articles Submit an Article Get RSS Feeds Add Free Article Content Most Viewed Latest Articles Article RatingsGuidelines
Authors PublishersPartners
ArticlesAreaZyprexa Lawsuit Cash Advance - No-Risk Lawsuit Loan
Submitted by Paul on Friday Sep 22, 2006 and viewed 812 timesTotal Word Count: 401
Author Rating: NA
Rate this article
|
Publisher
|
Print
A risk free source of legal finance is now available for plaintiffs involved in Zyprexa or other pharmaceutical lawsuits. It is called lawsuit funding or often referred as Lawsuit loans, Lawsuit funding, Legal finance, or a Personal injury settlement, but these are not loans because the money does not have to be paid back unless the case is won or settled.
Plaintiffs involved in pharmaceuticals lawsuits like Zyprexa and Fen-phen etc, can now get Lawsuit cash advances. 99% of plaintiffs involved in lawsuits do not realize they can get cash advance while they are waiting for their settlement money.
Zyprexa (olanzapine) is a second generation or atypical antipsychotic medication produced by Eli Lilly and company. Zyprexa was FDA approved for the short-term treatment of acute manic episodes in bipolar disorder.
In 2003 the FDA required that the class of drugs known as atypical antipsychotic, including Zyprexa, include warnings about increased risk to patients of development of diabetes and hyperglycemia. In 2004, a federal prosecutor announced an investigation of Eli Lilly, in relation to the techniques it has used to market Zyprexa.
To date, over 16 million people have used this drug. The FDA has identified there have been 384 reports of diabetes Zyprexa side effects, including 23 deaths. There have been many questions regarding the popular drug Zyprexa and its safety. The potentially fatal Zyprexa side effects have resulted in Zyprexa lawsuits.
A risk free source of legal finance is now available for plaintiffs involved in Zyprexa or other pharmaceutical lawsuits. It is called lawsuit funding or often referred as Lawsuit loans, Lawsuit funding, Legal finance, or a Personal injury settlement, but these are not loans because the money does not have to be paid back unless the case is won or settled.
Pharmaceutical drug litigation can take years to settle, which can be a problem if they are sick or are unable to work. They can have a solid pharmaceutical drug litigation claim and a strong legal team, but the drug companies have deep pockets.
It does not seem fair for the plaintiffs, that even if they have won their Zyprexa litigation, the money they get may come too late. They need money now. Most of the plaintiffs, because of their health conditions have missed work or lost their jobs. They can no longer meet their mortgage/ rent or car payments. Many of them may be one or two payments away from foreclosures. They may be in need of medical treatments. They need to pay education expenses of their children.
These are some genuine reasons for plaintiffs to go ahead and secure a lawsuit funding. I believe if a Zyprexa plaintiff is in dire financial straits, it may be appropriate to obtain a lawsuit loan, but from a good company only.
Zyprexa (olanzapine) is a second generation or atypical antipsychotic medication produced by Eli Lilly and company. Zyprexa was FDA approved for the short-term treatment of acute manic episodes in bipolar disorder.
In 2003 the FDA required that the class of drugs known as atypical antipsychotic, including Zyprexa, include warnings about increased risk to patients of development of diabetes and hyperglycemia. In 2004, a federal prosecutor announced an investigation of Eli Lilly, in relation to the techniques it has used to market Zyprexa.
To date, over 16 million people have used this drug. The FDA has identified there have been 384 reports of diabetes Zyprexa side effects, including 23 deaths. There have been many questions regarding the popular drug Zyprexa and its safety. The potentially fatal Zyprexa side effects have resulted in Zyprexa lawsuits.
A risk free source of legal finance is now available for plaintiffs involved in Zyprexa or other pharmaceutical lawsuits. It is called lawsuit funding or often referred as Lawsuit loans, Lawsuit funding, Legal finance, or a Personal injury settlement, but these are not loans because the money does not have to be paid back unless the case is won or settled.
Pharmaceutical drug litigation can take years to settle, which can be a problem if they are sick or are unable to work. They can have a solid pharmaceutical drug litigation claim and a strong legal team, but the drug companies have deep pockets.
It does not seem fair for the plaintiffs, that even if they have won their Zyprexa litigation, the money they get may come too late. They need money now. Most of the plaintiffs, because of their health conditions have missed work or lost their jobs. They can no longer meet their mortgage/ rent or car payments. Many of them may be one or two payments away from foreclosures. They may be in need of medical treatments. They need to pay education expenses of their children.
These are some genuine reasons for plaintiffs to go ahead and secure a lawsuit funding. I believe if a Zyprexa plaintiff is in dire financial straits, it may be appropriate to obtain a lawsuit loan, but from a good company only.
ArticleSource: ArticlesAlley.com
Number of ratings: 1
Rating: 5
Rating: 5